What can the world learn from lupus amidst this COVID-19 reality and beyond?

Find out here.

What Is Lupus?

Facts, symptoms and key questions

COVID-19 News

What you should know

Research and Clinical Trials

For lupus scientists and treatment professionals

Your Community

A place to find comfort and understanding

 

Why us?

Our funding is leading to key discoveries that are improving diagnosis and therapies, while enabling researchers to find the way toward prevention and ultimately a cure for lupus.

100% of funds

go to support
research programs

500 Grants

fostering scientific
breakthroughs

$200 million

in support of
cutting-edge research

Recent Lupus Research Breakthroughs

News and Events

Aurinia Completes NDA and Requests Priority Review of Voclosoporin by FDA for Lupus Nephritis

May 28, 2020 The Lupus Research Alliance is pleased to share that Aurinia Pharmaceuticals Inc submitted a New Drug...

Read More

COVID-19 Caused Hydroxychloroquine Issues for Third of Lupus Patients, New LRA Survey Finds

NEW YORK, NY, May 28. More than one third of people with lupus experienced significant issues filling their hydroxychloroquine...

Read More

Lupus and COVID-19: What You Need to Know – LIVE WEBCAST May 21 at 6 PM ET

Since the arrival of the novel coronavirus, lupus and the most prescribed drug used to treat it – hydroxychloroquine...

Read More
walk